SMARCA4 and cancer: Parallel evolution of five subclonal SMARCA4 mutations in this tumour with truncal ARID1A mutations suggests that SWI/SNF-complex aberrations are not only important for carcinogenesis but that progressive inactivation may contribute to cancer progression.